Harris Associates
AMGN icon

Harris Associates’s Amgen AMGN Stock Holding History

Harris Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,519
Closed -$401K – 169
2014
Q4 		$401K Sell
2,519
-518
-17% -$80.7K ﹤0.01% 164
2014
Q3 		$427K Hold
3,037
– – ﹤0.01% 156
2014
Q2 		$359K Sell
3,037
-18
-0.6% -$2.08K ﹤0.01% 164
2014
Q1 		$377K Hold
3,055
– – ﹤0.01% 166
2013
Q4 		$349K Sell
3,055
-181
-6% -$20.6K ﹤0.01% 171
2013
Q3 		$362K Hold
3,236
– – ﹤0.01% 166
2013
Q2 		$319K Buy
+3,236
New +$336K ﹤0.01% 174

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Harris Associates's AMGN Position: Q1 2015 in Review

Harris Associates sold out of Amgen (AMGN) in Q1 2015, closing a stake of 2,519 shares — an estimated $401K sold.

Harris Associates first reported a position in AMGN in Q2 2013 and held it in 7 quarters. The position peaked at $427K in Q3 2014. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • Harris Associates reported no remaining Amgen position as of Q1 2015 after selling out during the quarter.
  • Harris Associates sold 2,519 Amgen shares in Q1 2015, an estimated $401K.
  • Harris Associates first reported a position in Amgen in Q2 2013 and held it in 7 quarters.
  • Harris Associates's Amgen position peaked at $427K in Q3 2014.
  • 1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Harris Associates's 13F filing for Q1 2015, filed 14 May 2015.